ImmunoGen Stock Price (NASDAQ:IMGN)

Add to My Stocks
$4.33 $0.22 (5.35%) IMGN stock closing price Apr 25, 2017 (Closing)
YOUR DAILY UPDATE ON
IMGN
ImmunoGen
25 APR 2017
amigobulls logo
IMGN hand_up
IMGN vs S&P 500
Closing Price: Apr 25, 2017
IMGN
$4.33 ( 5.35%)
S&P 500
2388.6 ( 0.61%)
IMGN
52 Week Price Range
1 Year Return: -55.18%
Q4 Growth*
Poor
Profitable ?
No
net image
2016 Q4 Net Loss
-319.9%
home image
Rating
IMGN POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

ImmunoGen Snapshot Video

22 5 2

IMGN Stock Details

Prev Close* : $4.11
Market Cap:
$360.07M
Day Low: $4.15
52 Week Low: $1.51
Open: $4.17
Volume: 4600019
Day High: $4.63
52 Week High: $9.45
Dividend:
N/A

Latest Stock Market News

Latest Articles

ImmunoGen News - From Partners

IMGN Stockcharts

View IMGN PE ratio, PS ratio stocks charts and compare with peers.
IMGN Chart
Note: Compare ImmunoGen stock price history with the index and industry peers.

ImmunoGen Valuation

PS ratio (
price to sales ratio
)
7.76

IMGN Industry Peers

Company Price Change (%)
Tyme Technologies (TYMI)3.050.45 (12.86%)
Nutraceutical International (NUTR)31.550.25 (0.8%)
Cytomx Therapeutics (CTMX)16.650.17 (1.03%)
Roche Holdings (RHHBY)32.410.4 (1.25%)
Eli Lilly (LLY)81.22.22 (2.66%)
Takeda Pharma (TKPYY)24.250.15 (0.61%)
Amgen (AMGN)164.71.56 (0.96%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
CTI BioPharma (CTIC)4.260.28 (7.04%)
USANA Health Sciences (USNA)58.553.3 (5.97%)
Ignyta (RXDX)8.950.5 (5.92%)
ImmunoGen (IMGN)4.330.22 (5.35%)
MADRIGAL PHARMA (MDGL)16.730.83 (5.22%)
Valeant Pharmaceuticals Intl Inc (VRX)9.020.42 (4.88%)
Spectrum Pharma (SPPI)7.630.32 (4.38%)
Top gainers from Medical-Drugs industry
* As of Apr 25, 2017
CompanyPriceChange (%)
Karyopharm Therapeutics (KPTI)10.410.9 (7.96%)
Durect (DRRX)0.8430.05 (5.61%)
Genocea Biosciences (GNCA)6.860.24 (3.38%)
Nature's Sunshine Products (NATR)9.90.3 (2.94%)
Egalet (EGLT)4.230.11 (2.53%)
AcelRx Pharma (ACRX)2.550.05 (1.92%)
Esperion Therapeutics (ESPR)37.050.49 (1.31%)
Top losers from Medical-Drugs industry
* As of Apr 25, 2017

ImmunoGen, Inc. Stock News - Partner Headlines

ImmunoGen Financial Statements

income statement20162015201420132012
Net Sales Or Revenues60M18.02M48.3M30.06M2.61M
Net Income-143.66M-33.22M13.63M3.81M-24.39M
Total Operating Expense-46.24M34.51M26.3M27.11M
view ImmunoGen, Inc. income statement
balance sheet20152014201320122011
Total Assets251.58M128.54M202.52M230.83M208.21M
Total Liabilities268.26M51.07M72.48M94.84M92.87M
Shareholders Equity-16.68M77.47M130.03M135.99M115.34M
view ImmunoGen, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-9.55M-37.77M-25.05M-1.58M0.87M
Net Cash From (Used By) Operating Activities-65.49M-34.38M-21.62M-42.7M-24.03M
Increase (Decrease) In Prop Plant And Equipment-5.12M-2.59M-2.29M-2.03M-0.83M
view ImmunoGen, Inc. cashflow statement

ImmunoGen Stock Message Board

ImmunoGen stock price ended the last trading day at 4.11. ImmunoGen market capitalization is 360.07M and it represents the total market value of IMGN stock. ImmunoGen valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that ImmunoGen is worth a lot, it will most likely be reflected in an inflated ImmunoGen stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 2406822 IMGN shares were traded yesterday, and ImmunoGen stock chart shows that the IMGN stock quote hit a day high of 4.29 and day low of 3.98. The board of directors decide what percentage of a company's earnings will be paid out as dividends. ImmunoGen stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.